These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35485272)

  • 1. Public health considerations for transitioning beyond the acute phase of the COVID-19 pandemic in the EU/EEA.
    Suk JE; Pharris A; Beauté J; Colzani E; Needham H; Kinsman J; Niehus R; Grah R; Omokanye A; Plachouras D; Baka A; Prasse B; Sandmann F; Severi E; Alm E; Wiltshire E; Ciancio B
    Euro Surveill; 2022 Apr; 27(17):. PubMed ID: 35485272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.
    Eales O; Plank MJ; Cowling BJ; Howden BP; Kucharski AJ; Sullivan SG; Vandemaele K; Viboud C; Riley S; McCaw JM; Shearer FM
    Emerg Infect Dis; 2024 Feb; 30(2):. PubMed ID: 38190760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparedness of countries to face COVID-19 pandemic crisis: Strategic positioning and factors supporting effective strategies of prevention of pandemic threats.
    Coccia M
    Environ Res; 2022 Jan; 203():111678. PubMed ID: 34280421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian critical care nurses' knowledge, preparedness, and experiences of managing SARS-COV-2 and COVID-19 pandemic.
    Nahidi S; Sotomayor-Castillo C; Li C; Currey J; Elliott R; Shaban RZ
    Aust Crit Care; 2022 Jan; 35(1):22-27. PubMed ID: 34462194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control.
    Buchy P; Buisson Y; Cintra O; Dwyer DE; Nissen M; Ortiz de Lejarazu R; Petersen E
    Int J Infect Dis; 2021 Nov; 112():300-317. PubMed ID: 34563707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Singapore COVID-19 Pandemic Response as a Successful Model Framework for Low-Resource Health Care Settings in Africa?
    Kuguyo O; Kengne AP; Dandara C
    OMICS; 2020 Aug; 24(8):470-478. PubMed ID: 32552397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural insights and the evolving COVID-19 pandemic.
    de Bruin M; Suk JE; Baggio M; Blomquist SE; Falcon M; Forjaz MJ; Godoy-Ramirez K; Leurs M; Rodriguez-Blazquez C; Romay-Barja M; Uiters E; Kinsman J
    Euro Surveill; 2022 May; 27(18):. PubMed ID: 35514309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Review of the Technological Solutions to Analyse the Effects of Pandemic Outbreak on Human Lives.
    Shah I; Doshi C; Patel M; Tanwar S; Hong WC; Sharma R
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learnt from the COVID-19 pandemic in selected countries to inform strengthening of public health systems: a qualitative study.
    Cardwell K; Clyne B; Broderick N; Tyner B; Masukume G; Larkin L; McManus L; Carrigan M; Sharp M; Smith SM; Harrington P; Connolly M; Ryan M; O'Neill M
    Public Health; 2023 Dec; 225():343-352. PubMed ID: 37979311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies.
    Gontariuk M; Krafft T; Rehbock C; Townend D; Van der Auwermeulen L; Pilot E
    Front Public Health; 2021; 9():698995. PubMed ID: 34490183
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 Pandemic: What Can the West Learn From the East?
    Shokoohi M; Osooli M; Stranges S
    Int J Health Policy Manag; 2020 Oct; 9(10):436-438. PubMed ID: 32610736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Health Disparities to Hotspots to Public Health Strategies: The Impact of the COVID-19 Pandemic in North Carolina.
    Seña AC; Weber DJ
    N C Med J; 2021; 82(1):37-42. PubMed ID: 33397753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of mRNA vaccines in curtailing SARS-CoV-2 infection and disability leave utilisation among healthcare workers during the COVID-19 pandemic: cross-sectional analysis from a tertiary healthcare system in the Greater Houston metropolitan area.
    Vahidy FS; Pan AP; Hagan K; Bako AT; Sostman HD; Schwartz RL; Phillips R; Boom ML
    BMJ Open; 2021 Oct; 11(10):e054332. PubMed ID: 34642201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.